Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ipsen to conduct phase II study of tasquinimod in multiple tumor types

Oct. 19, 2012

Curis achieves first milestones in CUDC-907 development

Oct. 19, 2012

Japanese Foundation for Cancer Research presents new antibodies

Oct. 19, 2012

Progen Pharmaceuticals reports phase II data for PI-88 in melanoma

Oct. 19, 2012

Preclinical pharmacokinetic properties disclosed for G-773

Oct. 18, 2012

First-in-human study of ODM-201 shows good tolerability and anticancer activity in mCRPC

Oct. 18, 2012

Phase III axitinib study fails to meet primary endpoint

Oct. 18, 2012

Phase II Adcetris monotherapy trial initiated in untreated Hodgkin's lymphoma

Oct. 18, 2012

New PI3Kdelta inhibitors synthesized at Roche

Oct. 18, 2012

Italian group prepares new series of tyrosine kinase inhibitors

Oct. 18, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...